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Abstract
Background: Treatment for localized prostate cancer (PCa) can cause long-term changes in erectile functioning.
However, data on the importance of sexuality and possible consequences of altered erectile functioning on self-
esteem in men with localized PCa are lacking.
Methods: Self-report questionnaires were completed by 292 men with PCa, initially managed with active
surveillance (AS) or radical prostatectomy (RP). Independent t-tests were conducted to evaluate group
differences. A sequential multiple regression model was fitted to analyze the associations between the
importance of sexuality, changes in erectile functioning and impairment of self-esteem. Interaction effects
were tested using simple slope analyses.
Results: Participants were 70 ± 7.2 years old and 66.5% rated sex as being “rather/very important”. The two
groups differed markedly in changes in erectile functioning, importance of sexuality and impairment of self-
esteem (p < .001), with higher values in RP patients. Regression analysis showed that after adjustment for control
variables and importance of sexuality, changes in erectile functioning were still associated with impairment of self-
esteem (B = .668, SE = .069, p < .001). The interaction of changes in erectile functioning and importance of sexuality
reached significance (B = .318, SE = .062, p < .001).
Conclusions: RP patients report more changes in erectile functioning than AS patients. Moreover, in men with
localized PCa, erectile functioning and self-esteem are closely related. Sexuality seems to be important for the majority
of these men. Physicians should address the possibility of erectile dysfunction and its potential effects on psychological
well-being before the treatment decision.
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Background
Men who are diagnosed with localized prostate cancer
(PCa) have to choose among treatment options that differ
considerably in their invasiveness, [1] ranging from active
surveillance (AS) to radical prostatectomy (RP). In AS,
treatment is delayed until a predefined histological or bio-
chemical disease progression occurs, or until the patient
choses a different treatment strategy due to other reasons,
for example, cancer-related anxiety. [2] One of the most
important reasons that men opt for AS is the possible im-
pairment of sexual function as a side effect of invasive
treatment. [3] Negative effects of RP on sexual function
compared to AS have been summarized in systematic re-
views [4, 5] and were confirmed by the latest results from
the randomized controlled trial ProtecT that compared
RP to AS directly. [6] Recent research has also highlighted
a close association of PCa treatment and psychosexual
outcomes, such as sexual bother [7] and an impaired sense
of masculinity. [8] However, most studies dealing with
sexuality in PCa patients still focus on the physiological
aspects of sexuality despite the fact that an impairment of
erectile function has far-reaching consequences on men’s
quality of life. [9, 10] For most men, sexuality is a vital as-
pect of their male identity and an impairment of erectile
functioning may also affect their self-esteem (i.e. men’s
appraisal of their individual abilities combined with a sense
of self-worth [11]). [12–14]
Prostate cancer is typically a disease of older men. [16]
Therefore, one may assume that an impairment of erectile
functioning is negligible in most PCa patients. Eventually,
at the time of diagnosis, men are an average of about 70
years old. [17] However, to draw the conclusion that sexual-
ity plays a subordinate role in the process of decision-mak-
ing could mean to adapt the stereotype of sex unjustifiably
being “unseemly, even unnatural in the old.” [15] Indeed,
sexual activity decreases with increasing age. Nevertheless,
most older men still seem to experience sexual desire [15,
18] and also report being sexually active. [9, 19]
Although the relationship between erectile dysfunction
and self-esteem has been subject to previous studies [13,
20], no study, to the best of our knowledge, has examined
this association in men with localized PCa undergoing dif-
ferent treatment options. Additionally, data on the import-
ance of sexuality in this population are lacking. The
diagnosis of PCa might represent a critical life-event for
some men. One could therefore assume that the diagnosis
entails a change in men’s priorities: PCa and its treatment
may become the main focus whereas other aspects of qual-
ity of life, such as sexuality, may become of diminishing
relevance. In fact, studies with colorectal cancer patients
showed that the importance of sexuality decreased due to
the cancer experience [21]. It remains unclear, however,
whether this also applies to men with localized PCa. Our
study therefore seeks to find out how important sexuality
actually is for men with localized PCa. In addition, PCa
treatment and RP in particular can result in an abrupt
change of erectile functioning (in contrast to a normative,
more gradual worsening of erectile functioning with
increasing age). This does not allow for anticipating
non-normative changes in erectile functioning for men with
localized PCa after invasive treatment, which could also have
an impact on self-esteem.
This study seeks to close a twofold gap: On the one hand,
we wanted to assess the consequences of erectile dysfunc-
tion on PCa patients’ self-esteem and, on the other hand, we
wanted to shed light on the importance of sexuality in this
population of older men with PCa. More specifically, we
aimed at (1) comparing perceived changes in erectile func-
tioning, self-esteem, and the importance of sexuality in men
having opted for either RP or AS, and (2) assessing how
changes in erectile functioning for the worse affect PCa pa-
tients’ self-esteem, considering the importance of sexuality.
Methods
Study design, procedure and participants
The study was nested within the prospective, multicenter,
observational HAROW study, which included patients
newly diagnosed with localized PCa between July 2008 and
July 2013. [22] The present study was conducted in 2014:
378 men who had chosen RP as their primary treatment
were matched based on the time since treatment decision
to 378 men who had opted for AS. Men who opted for
radiation therapy were excluded from this study as it aimed
at comparing the two extremes of possible treatment strat-
egies (AS =minimally invasive vs. RP =maximally invasive).
All men contacted had agreed to take part in future studies.
Men in the high risk category, as defined by D’Amico and
colleagues, [23] were excluded from the study to improve
the balance of the two treatment groups (see Kendel and
colleagues for more details [24]). Those participants who
gave written consent to the follow-up were mailed a
self-report questionnaire. The average time from treatment
decision to follow-up was 42 ± 16.6months (range: 1–6
years).
The final sample comprised 292 men (150 RP patients,
142 AS patients). All participants had given informed
consent prior to the study. IRB approval was obtained from
the Charité – Universitätsmedizin Berlin (EA 1/242/13).
Materials and main outcome measures
Baseline clinical parameters were abstracted from case
report forms. Changes in erectile functioning (“Did your
erectile function change due to your prostate cancer or its
treatment?”) and impairment of self-esteem due to
decreased erectile functioning (“If your erectile function has
decreased, did this impair your self-esteem?”) were mea-
sured using items adapted from Johannson and colleagues.
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[25] The item measuring subjective importance of sexuality
(“How important is sexuality for you?”) was adapted from
van den Bergh and colleagues. [26] A five-point Likert scale
was used for the item on impairment of self-esteem (range
0–4 with 0 indicating no changes in erectile functioning
and therefore no impairment of self-esteem, 1 indicating
changes in erectile functioning but no impairment of
self-esteem due to these changes and 2–4 indicating
changes in erectile functioning with lower to high impair-
ment of self-esteem). For all other items, a four-point
Likert scale (range 1–4) was used, with higher levels indi-
cating higher expressions of the specific characteristic.
Previous studies have demonstrated that erectile dysfunc-
tion is not necessarily associated with decreased sexual
satisfaction. [9] Therefore, satisfaction with sexual life was
assessed as a control variable. The item (“Overall, how satis-
fied are you with your current sex-life?”) was adapted from
van den Bergh and colleagues. [26] A five-point Likert scale
was used for the item on satisfaction with sexual life (range
1–5, higher levels indicating higher expressions of satisfac
tion).
Statistical analysis
The RP and AS patients were compared regarding relevant
sociodemographic variables and cancer characteristics.
Chi2-tests were run for categorical variables and independ-
ent t-tests were conducted for continuous variables to
compare (a) changes in erectile functioning, (b) impairment
of self-esteem (c) the importance of sexuality and (d) satis-
faction with sexual life between the two groups. Cohen’s d
as a measure of effect size was calculated for group
comparisons. Bivariate correlations between variables were
calculated. A sequential multiple regression analysis was
conducted to evaluate the relationship between sociodemo-
graphic characteristics, clinical variables, the importance of
sexuality and changes in erectile functioning with the cri-
terion self-esteem. Covariates were entered first, followed
by the importance of sexuality, changes in erectile function-
ing and finally the interaction term. Within all regression
models, collinearity diagnostics indicated no multicollinear-
ity among the independent variables. For moderation ana-
lyses, [27] predictor variables and the constituents of the
respective interaction terms were centered around their
grand means. In moderation models, covariates were en-
tered first, followed by the importance of sexuality as mod-
erator and changes in erectile functioning as predictor, and
finally by the interaction term. To display and test the inter-
action effects, simple slopes were tested. [28] Low and high
values of the continuous moderators were generated by
adding or subtracting one standard deviation from the cen-
tered mean of the respective moderator. Moderation ana-
lyses were conducted using the PROCESS macro for SPSS
(model 1). [29] An alpha level of p < 0.05 was considered
significant for all analyses.
Results
Of the 292 men with PCa included in this study, 150
(51.4%) had chosen RP as the initial treatment and 142
(48.6%) were still under AS. Table 1 presents the sociodemo-
graphic data, clinical characteristics and descriptive statistics
based on the two different treatment groups. Table 2 dis-
plays correlations between the variables under study. Fewer
men after RP (69%) were classified as low-risk compared
with men under AS (88%). The two groups differed in age,
marital status, occupation, and initial cancer risk classifica-
tion (Table 1). The RP patients reported significantly more
changes in erectile functioning (t (246.8) = − 10.11, p < .001;
d = 1.2), and greater impairment of self-esteem (t (269) = −
4.19, p < .001, d= .51) than men under AS. On average, men
under AS considered sexuality as being less important
Table 1 Sample characteristics and sexuality
Total (n = 292) RP (n = 150) AS (n = 142) P
Age, yrs., M (SD) 70 (7.2) 67.9 (6.8) 72.2 (7.1) < .001
Living with partner, n (%) 268 (92.4) 140 (94) 128 (90.8) .031
Higher education, n (%) 116 (40) 61 (40.9) 54 (38.3) .737
Still working vs. retired, n (%) 40 (13.8) 28 (18.8) 12 (8.5) .04
Time since treatment decision (months), M (SD) 42 (16.6) 41.7 (16.3) 42.3 (17.1) .774
Risk classification1 < .001
Gleason-Score (low), n (%) 221 (76.7) 85 (57.8) 136 (96.5) < .001
PSA, M (SD) 6.2 (3.2) 6.9 (2.8) 5.5 (3.3) < .001
Number of comorbidities, M (SD) 1.8 (1.5) 1.8 (1.5) 1.8 (1.5) .713
Importance of sexuality, M (SD) 2.8 (0.8) 2.9 (0.8) 2.6 (0.85) < .001
Changes in erectile functioning, M (SD) 3 (0.99) 3.5 (0.7) 2.5 (0.99) < .001
Impairment of self-esteem, M (SD) 1.8 (1.15) 2.1 (1.1) 1.5 (1.1) < .001
Satisfaction with sexual life, M (SD) 2.8 (1) 2.7 (1.1) 3 (0.9) .002
AS, active surveillance, RP, radical prostatectomy; 1 Risk classification based on D’Amico and colleagues [23]
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compared to the RP patients (t (278.4) = − 3.54, p < .001; d
= .42). Across both groups, 66.5% of men rated sexuality as
“rather or very important” (59% of the AS patients, 73.5% of
the RP patients). The AS patients reported being more satis-
fied with their sexual life compared to RP patients (t (277.4)
= 3.17, p= .002, d = .38). The correlation between satisfac-
tion with sexual life and changes in erectile functioning was
r = −.42 (p < .001, Table 2).
Multiple regression analysis
Sequential multiple regression was used to determine
whether the importance of sexuality and changes in erectile
functioning predicted impairment of self-esteem (Table 3).
ΔR2 refers to the amount of variance in the criterion (im-
pairment of self-esteem), which is explained by the respect-
ive variables entered into the regression model at each step.
Sociodemographic variables were entered in the first step
and did not explain the variance of impairment of self-es-
teem significantly (p = .08). R2 was significantly different
from zero in the second step including treatment group
(ΔR2 = .06, p < .001), but not in the third to fifth step in-
cluding PSA and Gleason-Score (ΔR2 = .002, p = .725), time
since treatment decision (ΔR2 = .004, p = .271) and number
of comorbidities (ΔR2 = .01, p = .1). Again, R2 was signifi-
cantly different from zero when including importance of
sexuality (ΔR2 = .048, p < .001) and changes in erectile func-
tioning (ΔR2 = .207, p < .001). After the inclusion of changes
in erectile functioning, the control variable treatment group
was no longer significant. The interaction term of import-
ance of sexuality*changes in erectile functioning also
contributed significantly to an explanation of the variance
(ΔR2 = .062, p < .001).
The final model explained 42.6% of variance (R2 = .426;
adjusted R2 = .398), meaning that more than a third of the
variability in impairment of self-esteem is predicted by our
model. The pattern of results suggests that changes in
erectile functioning predicted more than a fifth (20.7%) of
the variability in impairment of self-esteem, whereas the
contribution of the importance of sexuality was small
(4.8%).
Moderation analysis
Moderation analysis revealed that the importance of
sexuality moderated effects of changes in erectile
Table 2 Correlations between study variables
Variables 2 3 4 5 6 7 8 9 10 11 12 13
1. Impairment of self-esteem .55** .26** .20** −.08 −.07 .01 .11 .04 −.04 .08 .09 −.56**
2. Changes in erectile functioning –
3. Importance of sexuality .23** –
4. Importance* changes EF −.12 −.14* –
5. Age −.16** −.34** .19** –
6. Living with partner .04 .13* −.05 −.03 –
7. Higher education .58 .03 −.04 −.03 .10 –
8. Still working .09 .23** <−.01 −.59** .08 .06 –
9. Time since treatment decision −.01 −.01 .03 .21** −.08 .06 −.13* –
10. Gleason-Score (low) −.27** −.13* .04 .09 .01 −.01 −.03 .02 –
11. PSA .17** <.01 −.04 .06 −.07 −.02 −.10 −.03 −.13* –
12. Number of comorbidities .11 −.07 .01 .07 −.04 −.05 <.01 .05 −.04 −.11 –
13. Satisfaction with sexual life −.42** −.09 −.20** −.01 −.01 .01 −.01 .04 .04 −.16** −.06 –
*p < .05; **p < .01
Table 3 Multiple regression of impairment of self-esteem on
the importance of sexuality and changes in erectile functioning:
final model (n = 277)
Variables B S.E. β ΔR2 (ad. R2)
Sociodemographic characteristics
Age .002 .011 .009
Living with a partner −.511 .216 −.117
Higher education −.05 .115 −.021
Still working vs. retired .137 .204 .042 .033
Group: RP vs. AS .016 .143 .007 .06
Tumor risk category
Gleason-Score (4–6) .305 .141 .116
PSA .004 .019 .012 .002
Time since treatment decision
(months)
.004 .004 .056 .004
Number of comorbidities .039 .039 .051 .01
Importance of sexuality .252 .074 .184 .048**
Changes in erectile functioning .668 .069 .567 .207***
Importance of sexuality*changes
in erectile functioning
.318 .062 .257 .062***
R2 = .426 Adjusted
R2 = .398 F = 14.93***
B, unstandardized regression coefficient, S.E., standard error; β, standardized
regression coefficient, AS, active surveillance, RP, radical prostatectomy;
**p < .01; ***p < .001
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functioning on impairment of self-esteem (Table 3). Sim-
ple slope analyses showed that for both individuals with
higher (B = .93, t = 10.43, p < .001) and lower importance
of sexuality (B = .40, t = 4.78, p < .001) changes in sexual
functioning more strongly affect their self-esteem, how-
ever this effect was weakened with lower importance of
sexuality (Fig. 1). We additionally tested the conditional
effect of changes in erectile functioning on impairment
of self-esteem if participants reported that sexuality was
“not at all” important to them. Then the effect was not
significant (B = .11, t = .85, p = .4), i.e. if sexuality is of no
importance changes in erectile functioning and
self-esteem are not associated.
Discussion
Our study aimed at evaluating the importance of sexuality
and the relationship of erectile functioning and self-esteem
among older men with localized PCa under different treat-
ment strategies. We have identified three key findings:
Firstly, age and, even more so, an invasive treatment for
PCa are predictive of changes in erectile functioning.
Secondly, even after adjustment for socio-demographic
and clinical variables, changes in erectile functioning prove
to be a strong predictor of self-esteem. Thirdly, the existing
relationship between erectile functioning and self-esteem
seems to be stronger in those men, for whom sexuality is
more important.
Our finding that RP is associated with poorer erectile
functioning is supported by findings of RCTs that provide
evidence for the invasive procedure being a causal factor.
[6, 30] In addition, the results of our study show that men
after AS consider sexuality as being less important com-
pared to men after RP. This finding may appear counterin-
tuitive at first sight as one could assume that AS is
predominantly chosen by those men who value sexuality as
more important. However, due to the cross-sectional
design of our study we cannot identify the time at which
sexuality became more important for RP patients. We
suggest that the higher importance of sexuality for men
after RP manifested after surgery: erectile dysfunction is a
common side-effect of RP and men and their partners have
to cope with this problem in the long-term. In this process,
sexuality may become a present, yet sensitive topic in men’s
everyday-life, which vice versa might change men’s attitude
towards sexuality.
Erectile functioning is a strong predictor for self-esteem
Erectile functioning explains more than a fifth of the
variance in self-esteem across both groups, after adjust-
ing for sociodemographic variables, group assignment
and the importance of sexuality. We challenged the
common stereotype portraying older people as “asexual”
by integrating the importance of sexuality in our study.
[18] It is often assumed that older people may no longer
consider sexuality an important aspect of their life and
would, therefore, see a worsening of their sexual function-
ing as irrelevant. Our results contradict this stereotype:
two thirds of the men, who were on average 70 years of
age, rated sexuality as being “rather or very important”.
However, even after adjusting for the importance of sexu-
ality, there was a stable association between worsened
sexual functioning and impaired self-esteem. This means
that even men who consider sexuality as less important
could experience an impairment of their self-esteem due
to changes in erectile functioning. This finding corre-
sponds with the results from a qualitative study by Gan-
non and colleagues, who supposed that the ability to
perform penetrative sex may be essential for male identity,
independent of a man’s actual sexual activity. [31] Only in
the small group of men (7% of our sample), who reported
that sexuality was of no importance to them, there was no
association between erectile functioning and self-esteem.
Changes in erectile functioning may have different
consequences for men with localized PCa
Our results show a strong association of erectile function-
ing and self-esteem for men with localized PCa. Moreover,
altered erectile functioning and satisfaction with sexual life
are negatively correlated in our sample. In a study with
men from the general population Braun and colleagues
demonstrated that only 14% of men aged 60 to 69 years re-
port having ED and being dissatisfied with their sex life. [9]
In our study, however, almost 40% of men who report at
least some changes in erectile functioning state that they
are “dissatisfied or very dissatisfied” with their sex life.
Thus, the consequences of erectile dysfunction might be
different for men with localized PCa compared to men
without PCa. After the diagnosis, men might address actual
or anticipated erectile dysfunction as a possible conse-
quence of invasive PCa treatment. The intensive
Fig. 1 The association of changes in erectile functioning and
impairment of self-esteem is stronger for men who report a
higher importance of sexuality
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preoccupation with implications of erectile dysfunction
may thus strengthen the association of erectile functioning
and self-esteem, whereas for men without PCa a decrease
in erectile functioning may be a simple expression of a nor-
mal aging process.
Strengths and limitations
The strengths of this study are a high external validity by
using a non-interventional, multicenter design, the length
of the follow-up and the sample size which represents one
of the largest samples for the comparison of RP and AS.
Additionally, our study focuses on the psychosocial aspects
of sexuality. While most studies addressing sexuality in
men with localized PCa focus more on physiological
aspects, we aimed to investigate the psychological aspects
of an altered sexuality. We selected our items measuring
men’s sexual life accordingly. However, the study is subject
to some limitations. (1) The cross-sectional and observa-
tional design does not allow for causal interpretations. For
example, it remains speculative whether a change in erectile
functioning for the worse leads to an impairment of
self-esteem, or whether there are additional confounding
variables. To deal with possible selection biases due to the
non-randomization, we controlled for several sociodemo-
graphic and clinical variables, which did not explain a sig-
nificant amount of variance. As opposed to a randomized
study, strengths of our observational design are a high
external validity and an exceptional participant rate. (2)
Our data are based on the participants’ self-reports of erect-
ile functioning and we did not validate the latter by object-
ive measures (e.g. medical records). However, the focus of
the study was on men’s subjective experience, which,
particularly regarding sexuality, seems more important than
objective parameters. [32] (3) Information on the psycho-
metric properties of measurement of sexuality used in our
study is still lacking. (4) Impairment of self-esteem was
assessed in the context of erectile functioning. As 90% of
our sample report having experienced at least some degree
of changes in erectile functioning it seems reasonable to
measure self-esteem in this way. However, the amount of
variance in self-esteem explained by erectile functioning in
our findings may be artificially inflated as a consequence.
Thus, independent measures of (impaired) self-esteem
should also be taken into account in future research. (5)
We did not assess whether men with impaired sexual func-
tioning made use of erection restoration treatments, which
could have had an impact on our results. Therefore, this as-
pect should be included and analysed in future studies.
Moreover, we are well aware that a differentiation between
homosexual and heterosexual men’s sexuality is desirable.
The importance of sexuality and erectile functioning
particularly when predicting self-esteem could differ among
these subgroups. Therefore, our findings may not gene
ralize regarding homosexual men. Finally, our sample
comprises a cohort that was operated in the years 2008 to
2013. Since then, great progress has been made in the field
of nerve-sparing PCa surgery. Hence, compared to the
present situation, the differences between AS and RP pa-
tients in this study may be more pronounced, and emphasis
should be given to the relationship between erectile func-
tioning, the importance of sexuality and self-esteem rather
than to the absolute differences.
Implications
Our results have some implications for future research.
Firstly, questionnaires on male sexuality in PCa patients
to date, focus primarily on the function rather than psy-
chological aspects of sexuality. An effort should be made
to develop questionnaires that comply with a broader
definition of sexuality as a holistic construct [15] and
meet the particularities of older men or PCa patients.
Widely accepted and validated questionnaires would also
facilitate a comparison of results. Secondly, longitudinal
studies in this field are desirable to gain a deeper insight
into the interplay of age, sexuality, self-esteem and other
psychosocial variables in men with PCa over time. As erect-
ile functioning is only one facet of the sexual response cycle
that can be affected by invasive PCa treatment more items
assessing sexual functioning should be included. Similarly,
self-esteem is only one example for the connection between
sexual functioning and psychological well-being. Future re-
search should take this into account.
Other implications refer to clinical practice. Previous
studies have shown that psychosocial interventions pro-
viding information or emotional support can improve
psychological outcomes in men with localized PCa. [33]
However, men with localized PCa stated not being in
need of psychosocial interventions in a qualitative study.
[34] Thus, despite of being potentially beneficial for men
with localized PCa the preliminary setting of psycho-
social interventions may not meet men’s needs. We
therefore suggest low-threshold services to counsel men
on PCa treatment, possible physiological side-effects and
associated psychological consequences. This could be
put into practice using online tools or by extending the
role of the urologist: For men with localized PCa, the ur-
ologist is usually the first and probably the most import-
ant specialist contact person. With urologists not only
giving medical but also psychological advice PCa pa-
tients would receive comprehensive consulting without
having to make additional efforts. A specific clinical im-
plication of our study concerning medical practice is to
structure the doctor-patient conversation about sexual-
ity. Many men still have difficulties discussing this topic
with their physician. However, they feel their physician
should address it on his or her own volition. The discus-
sion about adverse effects of an invasive treatment
should comprise the psychological impact of an
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impairment of erectile functioning to reach a fully in-
formed decision. Furthermore, the physician is crucial
for rebutting stereotypes for men who experience an im-
pairment of erectile functioning due to invasive treat-
ment or age. The physician may discuss with the patient
that the stereotype of older people being asexual, focus-
ing mainly on the degree of erectile functioning, is based
on a “too narrow definition of sexuality.” [18] Profes-
sionals could encourage their patients to maintain their
sexual life and, when being sexually active, to use “what
they have.” [15] Low-threshold services (e.g. online con-
sulting tools) and interventions aiming to improve the
communication of sensitive (psychological) topics should
be conceptualized and tested in future research.
Conclusions
The effect of erectile dysfunction on men’s self-esteem is a
neglected topic in PCa research that deserves attention in
both clinical practice and research. Changes in erectile
functioning may become particularly important if they
occur due to a PCa treatment. Our results emphasize the
importance of sexuality for men with PCa. Therefore,
medical advice on PCa treatment should encompass the
strong association of erectile dysfunction and self-esteem
in men with PCa. This topic should be addressed as a
possible consequence of invasive treatment.
Abbreviations
AS: Active surveillance; E.g: Exempli gratia; I.e: Id est.; PCa: Prostate cancer;
RP: Radical prostatectomy
Acknowledgements
We thank the study participants who provided their time and showed great
interest in this study. We would particularly like to thank Hans-Jörg Fiebrandt
and the German Association of Prostate Cancer Self-Help for their encour-
agement. We would like to thank the Stiftung Männergesundheit Foundation
for their cooperation.
Funding
This research was funded by the Stiftung Oskar-Helene-Heim Foundation.
The funding source had no role in the design of the study, collection, ana-
lysis, and interpretation of data and in writing the manuscript. We acknow-
ledge support from the German Research Foundation (DFG) and the Open
Access Publication Fund of Charité – Universitätsmedizin Berlin.
Availability of data and materials
The datasets generated and/or analysed during the current study are not
publicly available due participant anonymization but are available from the
corresponding author on reasonable request.
Authors’ contributions
FK and CH conceptualized the study and developed the research questions.
FK and CH were also responsible for the acquisition of data. FK, SH, and CH
analyzed and interpreted the data; AM, MS, SN, and TF also contributed to
the interpretation of data. FK and CH drafted the article which was then
revised by SH, SN, MS, AM, and TH. All authors read and approved the final
manuscript.
Ethics approval and consent to participate
Ethics approval was obtained from the Charité – Universitätsmedizin Berlin
(EA 1/242/13). All participants had given prior written consent to study




The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Institute of Medical Psychology, Charité Universitätsmedizin Berlin, D-10117
Berlin, Germany. 2Department of Urology and Pediatric Urology, Otto von
Guericke University Magdeburg, Magdeburg, Germany. 3Department of
Urology, Klinik am Ring Cologne, Cologne, Germany. 4Department of
Urology, Vivantes Klinikum am Urban Berlin, Berlin, Germany. 5Institute of
Psychology, Humboldt-Universität zu Berlin, Berlin, Germany. 6Department of
Psychology, University of Applied Sciences Europe, Berlin, Germany.
Received: 1 June 2018 Accepted: 9 January 2019
References
1. Agency for Healthcare Research and Quality (US). Therapies for clinically
localized prostate cancer. Update of a 2008 systematic review: Rockville
(MD) 2014.
2. Latini DM, Hart SL, Knight SJ, Cowan JE, Ross PL, Duchane J, Carroll PR. The
relationship between anxiety and time to treatment for patients with
prostate cancer on surveillance. J Urol. 2007;178:826–32.
3. Bellardita L, Valdagni R, van den Bergh R, Randsdorp H, Repetto C, Venderbos
LDF, Lane JA, Korfage IJ. How does active surveillance for prostate cancer
affect quality of life? A systematic review. Eur Urol. 2015;67:637–45.
4. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic
review: comparative effectiveness and harms of treatments for clinically
localized prostate cancer. Ann Intern Med. 2008;148:435–48.
5. Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, Gleitsmann K,
Koenig HC, Lam C, Maltz A, Rugge JB, Lin K. Screening for prostate cancer: a
review of the evidence for the U.S. preventive services task force. Ann Intern
Med. 2011;155:762–71.
6. Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, Blazeby JM,
Peters TJ, Holding P, Bonnington S, Lennon T, Bradshaw L, Cooper D,
Herbert P, Howson J, Jones A, Lyons N, Salter E, Thompson P, Tidball S,
Blaikie J, Gray C, Bollina P, Catto J, Doble A, Doherty A, Gillatt D,
Kockelbergh R, Kynaston H, Paul A, Powell P, Prescott S, Rosario DJ, Rowe E,
Davis M, Turner EL, Martin RM, Neal DE. Patient-reported outcomes after
monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med.
2016;375:1425–37.
7. Zaider T, Manne S, Nelson C, Mulhall J, Kissane D. Loss of masculine identity,
marital affection, and sexual bother in men with localized prostate cancer. J
Sex Med. 2012;9:2724–32.
8. Chambers SK, Chung E, Wittert G, Hyde MK. Erectile dysfunction,
masculinity, and psychosocial outcomes: a review of the experiences of
men after prostate cancer treatment. Transl Androl Urol. 2017;6:60–8.
9. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U.
Epidemiology of erectile dysfunction: results of the 'Cologne male Survey'.
Int J Impot Res. 2000;12:305–11.
10. Wittmann D, Carolan M, Given B, Skolarus TA, Crossley H, An L, Palapattu G,
Clark P, Montie JE. What couples say about their recovery of sexual intimacy
after prostatectomy: toward the development of a conceptual model of
couples' sexual recovery after surgery for prostate cancer. J Sex Med. 2015;
12:494–504.
11. Mruk CJ. Defining self-esteem as a relationship between competence and
worthiness: how a two-factor approach integrates the cognitive and
affective dimensions of self-esteem. Pol Psychol Bull. 2013;44:157–64.
12. McMahon CG. Erectile dysfunction. Int Med J. 2014;44:18–26.
13. Mulhall J, Althof SE, Brock GB, Goldstein I, Junemann K-P, Kirby M. Erectile
dysfunction: monitoring response to treatment in clinical practice -
recommendations of an international study panel. J Sex Med. 2007;4:448–64.
14. Kogel AM, Dinkel A, Marten-Mittag B, Baron J, Albers P, Arsov C, Hadaschik
B, Hohenfellner M, Imkamp F, Kuczyk M, Gschwend JE, Herkommer K.
Hilger et al. BMC Urology            (2019) 19:9 Page 7 of 8
Selbstbild und erektile Dysfunktion 45-jahriger Manner. Ergebnisse eines
Begleitprojekts der PROBASE-Studie. Urologe A. 2016;55:1321–8.
15. DeLamater JD, Sill M. Sexual desire in later life. J Sex Res. 2005;42:138–49.
16. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;
65:5–29.




18. Kenny RT. A review of the literature on sexual development of older adults
in relation to the asexual stereotype of older adults. CJFY. 2013;5:91–106.
19. Corona G, Rastrelli G, Maseroli E, Forti G, Maggi M. Sexual function of the
ageing male. Best Pract Res Clin Endocrinol Metab. 2013;27:581–601.
20. Lowy M, Collins S, Bloch M, Gillman M, Lording D, Sutherland P, Wang H,
Stecher V. Quality of erection questionnaire correlates: change in erection
quality with erectile function, hardness, and psychosocial measures in men
treated with sildenafil for erectile dysfunction. J Sex Med. 2007;4:83–92.
21. Reese JB, Haythornthwaite JA. Importance of sexuality in colorectal cancer:
predictors, changes, and response to an intimacy enhancement
intervention. Support Care Cancer. 2016;24:4309–17.
22. Herden J, Eminaga O, Wille S, Weissbach L. Treatment of incidental prostate cancer
by active surveillance: results of the HAROW study. Urol Int. 2015;95:209–15.
23. D'Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D,
Chen M-H, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Biochemical
outcome after radical prostatectomy or external beam radiation therapy for
patients with clinically localized prostate carcinoma in the prostate specific
antigen era. Cancer. 2002;95:281–6.
24. Kendel F, Helbig L, Neumann K, Herden J, Stephan C, Schrader M,
Gaissmaier W. Patients' perceptions of mortality risk for localized prostate
cancer vary markedly depending on their treatment strategy. Int J Cancer.
2016;139:749–53.
25. Johansson E, Steineck G, Holmberg L, Johansson J-E, Nyberg T, Ruutu M,
Bill-Axelson A. Long-term quality-of-life outcomes after radical
prostatectomy or watchful waiting. The Scandinavian prostate Cancer
Group-4 randomised trial. Lancet Oncol. 2011;12:891–9.
26. van den Bergh R, Korfage IJ, Roobol MJ, Bangma CH, de KHJ, Steyerberg
EW, Essink-Bot M-L. Sexual function with localized prostate cancer: active
surveillance vs radical therapy. BJU Int. 2012;110:1032–9.
27. Aiken LS, West SG. Multiple regression. Testing and interpreting interactions,
vol. XI. 4th ed. Newbury Park Calif: Sage Publ; 1996. p. 212 S.
28. Preacher KJ, Curran PJ, Bauer DJ. Computational tools for probing
interaction effects in multiple linear regression, multilevel modeling, and
latent curve analysis. J Educ Behav Stat. 2006:437–48.
29. Hayes AF. PROCESS: a versatile computational tool for observed variable
mediation, moderation, and conditional process modeling [white paper].
2012. http://www.afhayes.com/public/process2012.pdf
30. Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson J-E, Norlen BJ,
Holmberg L. Quality of life after radical prostatectomy or watchful waiting.
N Engl J Med. 2002;347:790–6.
31. Gannon K, Guerro-Blanco M, Patel A, Abel P. Re-constructing masculinity
following radical prostatectomy for prostate cancer. Aging Male. 2010;13:258–64.
32. Owczarek K. The concept of quality of life. Acta Neuropsychol. 2010;8:207–13.
33. Weber BA, Sherwill-Navarro P. Psychosocial consequences of prostate
cancer: 30 years of research. Geriatr Nurs. 2005;26:166–75.
34. Oliffe JL, Davison BJ, Pickles T, Mróz L. The self-management of uncertainty
among men undertaking active surveillance for low-risk prostate cancer.
Qual Health Res. 2009;19:432–43.
Hilger et al. BMC Urology            (2019) 19:9 Page 8 of 8
